This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0-ballot: STU 1 Ballot 3) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-lansoprazole | Version: 1.0.0-ballot | |||
| Draft as of 2018-07-02 | Computable Name: Valueset_lansoprazole | |||
Copyright/Legal: (copyright expectations unknown) |
||||
ValueSet containing drug identifiers for lansoprazole.
References
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 83156 | Prevacid |
| 757969 | {4 (Amoxicillin 500 MG Oral Capsule [Trimox]) / 2 (Clarithromycin 500 MG Oral Tablet [Biaxin]) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid]) } Pack [Prevpac] |
| 758486 | {7 (lansoprazole 15 MG Delayed Release Oral Capsule) / 14 (Naproxen 375 MG Oral Tablet) } Pack |
| 758497 | {7 (lansoprazole 15 MG Delayed Release Oral Capsule) / 14 (Naproxen 500 MG Oral Tablet) } Pack |
| 757968 | {4 (Amoxicillin 500 MG Oral Capsule) / 2 (Clarithromycin 500 MG Oral Tablet) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule) } Pack |
| 17128 | lansoprazole |
| 206205 | lansoprazole 15 MG Disintegrating Oral Tablet [Prevacid] |
| 206206 | lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid] |
| 596918 | lansoprazole 15 MG Delayed Release Oral Capsule [Prevacid] |
| 866152 | lansoprazole 30 MG Disintegrating Oral Tablet [Prevacid] |
| 541184 | lansoprazole 15 MG [Prevacid] |
| 541188 | lansoprazole 30 MG [Prevacid] |
| 379705 | lansoprazole Delayed Release Oral Capsule [Prevacid] |
| 844359 | lansoprazole Disintegrating Oral Tablet [Prevacid] |
| 311277 | lansoprazole 30 MG Delayed Release Oral Capsule |
| 351260 | lansoprazole 30 MG Disintegrating Oral Tablet |
| 351261 | lansoprazole 15 MG Disintegrating Oral Tablet |
| 596843 | lansoprazole 15 MG Delayed Release Oral Capsule |
| 791878 | lansoprazole 0.5 MG/ML Oral Suspension |
| 791880 | lansoprazole 1 MG/ML Oral Suspension |
| 477260 | lansoprazole 6 MG/ML Injectable Solution |
| 343086 | lansoprazole 15 MG |
| 343108 | lansoprazole 30 MG |
| 353363 | lansoprazole 1 MG/ML |
| 353364 | lansoprazole 0.5 MG/ML |
| 477261 | lansoprazole 6 MG/ML |
| 378648 | lansoprazole Delayed Release Oral Capsule |
| 477263 | lansoprazole Injectable Solution |
| 562810 | lansoprazole Oral Suspension |
| 706238 | lansoprazole Disintegrating Oral Tablet |
| 1162543 | lansoprazole Injectable Product |
| 1162544 | lansoprazole Oral Liquid Product |
| 1162545 | lansoprazole Oral Product |
| 1162546 | lansoprazole Pill |
| 1295364 | lansoprazole Disintegrating Oral Product |
| 1177101 | Prevacid Oral Product |
| 1177102 | Prevacid Pill |
| 1296812 | Prevacid Disintegrating Oral Product |
This value set contains 38 concepts
Expansion based on RxNorm version ??
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |